Hec Pharm Company Profile
✉ Email this page to a colleague
What is the competitive landscape for HEC PHARM, and what generic and branded alternatives to HEC PHARM drugs are available?
HEC PHARM has seven approved drugs.
Drugs and US Patents for Hec Pharm
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Hec Pharm | LEVOFLOXACIN | levofloxacin | TABLET;ORAL | 204968-002 | Feb 5, 2019 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Hec Pharm | LEVOFLOXACIN | levofloxacin | TABLET;ORAL | 204968-001 | Feb 5, 2019 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Hec Pharm | OLANZAPINE | olanzapine | TABLET, ORALLY DISINTEGRATING;ORAL | 208146-004 | Jul 2, 2018 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.